课题基金 / 基金详情

Simultaneous analysis of cell-borne and soluble biomarkers by high throughput acoustic flow cytometry

Simultaneous analysis of cell-borne and soluble biomarkers by high throughput acoustic flow cytometry
通过高通量声学流式细胞术同时分析细胞源性和可溶性生物标志物
批准号:
10602869
负责人:
John Peter O'Rourke
金额:
$27.52万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
已结题
起止时间:
2023-03-01 至 2024-02-29

项目摘要

项目成果

John Peter O'Rourke的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Project Summary Analysis of complex cellular processes in understanding disease, development of drugs, or testing efficacy of therapies often requires dynamic measurements of both cellular markers and cellular products. The ability to synchronously and rapidly conduct such measurements in complex cell- containing samples using a single instrumental analysis will be useful and beneficial across biotechnology. The goal of this project is to enable such multiplex analysis of T-cell activation using immunophenotyping and quantitative monitoring of their secreted cytokines as an important model system. High throughput measurement of samples of suspended cells is made possible using BennuBio’s Velocyt® multi-stream acoustic flow cytometry system. The primary innovation of this project is the implementation of negative acoustic contrast particles (NACPs) as a bead-based immunoassay platform that significantly extends the analytical capabilities of the Velocyt® instrument for simultaneous analysis of cell-associated and soluble biomarkers. In contrast to cells, which migrate to, and are analyzed at, discreet positions within the Velocyt® flow stream,NACPs are separated to distinct positions in the flow stream, allowing for easy discrimination between bead and cells in a single sample. In this proof-of-concept Phase I research, we aim to conduct simultaneous measurement of the T-cell activation marker CD25 in both the CD4 and CD8 population at the same time that we measure secreted interferon-γ and tumor necrosis factor-α . While this demonstration will be of significance to the development of pharmaceuticals for treatment of a range of immunological and infectious diseases that involve T-cell activation, it will also provide a firm basis by which to design and commercialize customizable NACP-based reagent kits to address a wide range of disciplines across biotechnology.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
VECTORS DIRECTING PERSISTENT MYELOID GENE EXPRESSION
  • 批准号:
    6526625
  • 项目类别:
  • 资助金额:
    $4.62万
  • 财政年份:
    2002
  • 负责人:
    John Peter O'Rourke
  • 依托单位:
VECTORS DIRECTING PERSISTENT MYELOID GENE EXPRESSION
VECTORS DIRECTING PERSISTENT MYELOID GENE EXPRESSION
海外基金